Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human SLC5A2 Deficiency and the Glucagon-Incretin Axis: A Pilot Study

NCT03965000 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT03965000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03965000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human SLC5A2 Deficiency and the Glucagon-Incretin Axis: A Pilot Study
Lead sponsor
Medical University Innsbruck
Phase
Observational
Overall status
Unknown status
Start date
January 24, 2019
Completion date
January 31, 2022
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, diabetes mellitus, familial renal glucosuria